Menu
11/07/2008
State Of The Art Athlone Factory Opened
Mary O'Rourke TD has official opened the new, extended state-of-the-art pharmaceutical laboratory facility for Intertek BioClin at Monksland in Athlone.
Intertek, a global company listed on the London Stock Exchange, is a leading provider of quality and safety solutions serving a wide range of industries around the world.
Intertek acquired the BioClin Research Laboratories in February this year from its Irish-owners.
It has extended and enhanced the facilities, which continue to be locally run and managed, to increase the businesses ability to support the Irish and international pharmaceutical industry.
Ireland is a key European centre for pharmaceutical manufacturing, and increasingly R&D, with many of the world's top-selling drugs being produced in Ireland.
Mary O'Rourke said: "Intertek's investment in BioClin and this new, larger purpose-designed facility is excellent news for Athlone and the surrounding region. Intertek's investment is a superb endorsement of the calibre of the services that Irish people and companies can provide to international business."
At 9,500 sq ft it is around 40% larger than the original 6,000 sq ft facility operated in Athlone for the past five years. It employs 20 people, 95% of whom are science graduates or post graduates.
Wolfhart Hauser, Intertek's CEO, said: "As Intertek's first significant laboratory in Ireland, we are pleased to bring the reach of our global network of quality and safety services and laboratories to Irish business looking to trade globally and support business growth in Athlone and greater Ireland."
Dr. John Conti-Ramsden, Global Director of Intertek's Pharmaceutical Services, said: "This expansion consolidates and enhances the level of services we can provide to the pharmaceutical R&D industry not just in Ireland, but now also overseas through Intertek's reach."
(PR/JM)
Intertek, a global company listed on the London Stock Exchange, is a leading provider of quality and safety solutions serving a wide range of industries around the world.
Intertek acquired the BioClin Research Laboratories in February this year from its Irish-owners.
It has extended and enhanced the facilities, which continue to be locally run and managed, to increase the businesses ability to support the Irish and international pharmaceutical industry.
Ireland is a key European centre for pharmaceutical manufacturing, and increasingly R&D, with many of the world's top-selling drugs being produced in Ireland.
Mary O'Rourke said: "Intertek's investment in BioClin and this new, larger purpose-designed facility is excellent news for Athlone and the surrounding region. Intertek's investment is a superb endorsement of the calibre of the services that Irish people and companies can provide to international business."
At 9,500 sq ft it is around 40% larger than the original 6,000 sq ft facility operated in Athlone for the past five years. It employs 20 people, 95% of whom are science graduates or post graduates.
Wolfhart Hauser, Intertek's CEO, said: "As Intertek's first significant laboratory in Ireland, we are pleased to bring the reach of our global network of quality and safety services and laboratories to Irish business looking to trade globally and support business growth in Athlone and greater Ireland."
Dr. John Conti-Ramsden, Global Director of Intertek's Pharmaceutical Services, said: "This expansion consolidates and enhances the level of services we can provide to the pharmaceutical R&D industry not just in Ireland, but now also overseas through Intertek's reach."
(PR/JM)
Related Northern Ireland Recruitment News Stories
Click here for the latest headlines.
13 February 2012
Abbott To Invest €85m In Pharmaceutical Expansion
Abbott plans to invest €85 million at its pharmaceutical manufacturing operation in Sligo. The investment will result in the creation of up to approximately 175 highly skilled jobs. The expansion of the facility will be completed in 2014. The investment is supported by the Irish Government through IDA Ireland.
Abbott To Invest €85m In Pharmaceutical Expansion
Abbott plans to invest €85 million at its pharmaceutical manufacturing operation in Sligo. The investment will result in the creation of up to approximately 175 highly skilled jobs. The expansion of the facility will be completed in 2014. The investment is supported by the Irish Government through IDA Ireland.
18 December 2008
Athlone Wins Pharmaceutical Jobs
An American pharmaceutical research company have announced some 200 jobs for Co Westmeath. According to reports this morning the company, Pharmaceutical Product Development (PPD), is to open a base at the IDA Garrycastle Business and Technology Park in Athlone. Executives from PPD will be in Athlone this morning to confirm details of the jobs.
Athlone Wins Pharmaceutical Jobs
An American pharmaceutical research company have announced some 200 jobs for Co Westmeath. According to reports this morning the company, Pharmaceutical Product Development (PPD), is to open a base at the IDA Garrycastle Business and Technology Park in Athlone. Executives from PPD will be in Athlone this morning to confirm details of the jobs.
11 May 2009
Unions Meet DHL After Cuts Announcement
Emergency talks are under way at Liberty Hall in Dublin between management and unions at logistics firm, DHL. The meeting comes after an announcement last week that major cuts in the domestic delivery facility at DHL Express would be made.
Unions Meet DHL After Cuts Announcement
Emergency talks are under way at Liberty Hall in Dublin between management and unions at logistics firm, DHL. The meeting comes after an announcement last week that major cuts in the domestic delivery facility at DHL Express would be made.
29 November 2013
A Wear And MSD Pharmaceuticals Announce Job Losses
Fianna Fáil Spokesperson on Jobs Dara Calleary has said it's a dark day on the jobs front, as MSD Pharmaceuticals announces plans to shut down its Swords operation and high street retailer A Wear goes into receivership. "We are talking about the potential loss of 928 jobs at two of the country's major employers.
A Wear And MSD Pharmaceuticals Announce Job Losses
Fianna Fáil Spokesperson on Jobs Dara Calleary has said it's a dark day on the jobs front, as MSD Pharmaceuticals announces plans to shut down its Swords operation and high street retailer A Wear goes into receivership. "We are talking about the potential loss of 928 jobs at two of the country's major employers.
27 April 2017
Pharmaceutical Firm Create 150 Jobs
Pharmaceutical firm Shire has announced the opening of its new office in Ireland at the Miesian Plaza on Dublin's Baggot Street, with the creation of 150 jobs.
Pharmaceutical Firm Create 150 Jobs
Pharmaceutical firm Shire has announced the opening of its new office in Ireland at the Miesian Plaza on Dublin's Baggot Street, with the creation of 150 jobs.
-
Northern Ireland WeatherThis Evening and Tonight:A dry night, save for a few light showers around the coasts, with prolonged clear spells and light winds bringing a frosty dawn for many in central and southern parts. Minimum temperature -3 °C.
